Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 3CNS 3Lymphoid 2Gynecologic 2Breast 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Malignant Neoplasms of Digestive Organs 1

Interventions

Biopsy 4Cyclophosphamide 3Microarray Analysis 2Methylprednisolone 2Filgrastim 2Colposcopy 2Carboplatin 2toripalimab 1tipifarnib 1sargramostim 1sapanisertib 1pyroxamide 1pirfenidone 1penpulimab 1palbociclib 1liposomal doxorubicin 1iodixanol 1human papillomavirus vaccine, TA 1artemisinin 1arginine butyrate 1Zoledronic Acid 1Vincristine 1Video-Assisted Surgery 1Topotecan 1Tetradecanoylphorbol Acetate 1Taxes 1Tacrolimus 1Specimen Handling 1Sorafenib 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × sapanisertib × Other neoplasm × Clear all
NCT02812056 2017-03-27

Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies

M.D. Anderson Cancer Center

Phase 1 Withdrawn
Other neoplasm

Malignant Neoplasms of Digestive Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡